SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Infectious Diseases Referral — John Henry Holliday

PatientJohn Henry Holliday
Date of birth2004-08-14
IdentifiersMRN HR-NI007-SYN; SSN (made up) 000-07-8153
Document date2026-02-10
AuthorMartin Beaumont, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

New cavitary, smear-positive pulmonary tuberculosis in a 21-year-old dentist who drinks heavily. Please confirm the regimen and doses, advise on liver monitoring given his alcohol use, and advise on isolation, return to dental work, and the length of treatment. [S]

Urgency: Urgent, within two weeks, on the same day as his two-week primary care visit. [S]

Questions for the consultant:

History of Present Illness

Two months of cough, blood-streaked sputum, night sweats, and weight loss to 58.0 kg (BMI 18.3); temperature 37.8 °C, oxygen saturation 95 percent. Chest X-ray: right upper lobe consolidation with a 3 cm cavity. First sputum smear for acid-fast bacilli 2+ today; two early-morning samples to follow, and a nucleic acid amplification test, culture, and susceptibility testing ordered. HIV, hepatitis B, and hepatitis C tests sent. Baseline ALT 34, AST 38, bilirubin 0.6, GGT 78 (high), albumin 3.4 (low), hemoglobin 12.6 (low), platelets 412 (high), HbA1c 5.2, creatinine 0.86. Visual acuity 85 letters in each eye with normal color vision. Alcohol: AUDIT 15, whiskey four or more evenings a week, often six or more drinks, mostly at late-night card games; mild alcohol use disorder; brief intervention given; safety assessment with no current risk. No other medicines; no known allergies. Plan: isoniazid 300 mg, rifampin 600 mg, pyrazinamide 1500 mg, ethambutol 1200 mg, and pyridoxine 50 mg daily by video-observed therapy with the health department, starting as soon as the amplification test confirms tuberculosis. Reported to the health department today; isolating at home [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

1 later historical claim is omitted because it describes events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Problems

ProblemClinical statusVerificationCodeProvenance
Pulmonary tuberculosis, right upper lobe cavitary, sputum smear-positive, confirmed by nucleic acid amplification without rifampin resistanceactiveconfirmed A15.0S — Synthetic modern coding of his documented pulmonary tuberculosis at the time of diagnosis; the bacteriology is synthetic.
Alcohol use disorder, mild, with binge drinkingactiveconfirmed F10.10S — Synthetic modern coding anchored to the documented heavy drinking; the severity and the criteria met are synthetic.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1872Developed a bad cough shortly after beginning to practice dentistryD (CLM-0004)

Family History

RelativeConditionAge at deathEvidence
motherPulmonary tuberculosis; died of it in 1866D (CLM-0002)

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-02-10Body height178cmS
2026-02-10Body weight58kgS
2026-02-10Body mass index (BMI) [Ratio]18.3kg/m2S
2026-02-10Systolic blood pressure112mm[Hg]S
2026-02-10Diastolic blood pressure70mm[Hg]S
2026-02-10Heart rate104/minS
2026-02-10Respiratory rate20/minS
2026-02-10Body temperature37.8CelS
2026-02-10Oxygen saturation in Arterial blood by Pulse oximetry95%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-02-10Hemoglobin [Mass/volume] in Blood12.6g/dL13.2-16.6 g/dLLowS
2026-02-10Leukocytes [#/volume] in Blood by Automated count9.410*3/uL4-11 10*3/uLNormalS
2026-02-10Platelets [#/volume] in Blood by Automated count41210*3/uL150-400 10*3/uLHighS
2026-02-10Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma34U/L7-56 U/LNormalS
2026-02-10Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma38U/L10-40 U/LNormalS
2026-02-10Bilirubin.total [Mass/volume] in Serum or Plasma0.6mg/dL0.1-1.2 mg/dLNormalS
2026-02-10Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma92U/L40-129 U/LNormalS
2026-02-10Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma78U/L8-61 U/LHighS
2026-02-10Albumin [Mass/volume] in Serum or Plasma3.4g/dL3.5-5 g/dLLowS
2026-02-10Creatinine [Mass/volume] in Serum or Plasma0.86mg/dL0.74-1.35 mg/dLNormalS
2026-02-10Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M124mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-02-10Glucose [Mass/volume] in Serum or Plasma90mg/dL70-99 mg/dLNormalS
2026-02-10Hemoglobin A1c/Hemoglobin.total in Blood5.2%<=5.6%NormalS
2026-02-10Visual acuity uncorrected Right eye by ETDRS eye chart85{letters}>=80NormalS
2026-02-10Visual acuity uncorrected Left eye by ETDRS eye chart85{letters}>=80NormalS
2026-02-10Total score [AUDIT]15{score}S
2026-02-10Total score [AUDIT-C]9{score}S
2026-02-10Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S

Assessment

Plan of Treatment